Another study found that chimeric antigen receptor‐T (CAR‐T) cells targeting CXCR5 can remove tumor cells with high CXCR5 expression from B cell follicles of lymphoid organs, especially in the treatment of follicular lymphoma and chronic lymphocytic leukemia.23 Here, CXCR5 is linked to B-cell chronic lymphocytic leukemia.